
Averna Therapeutics
Developer of genomic medicine intended to transform the treatment of a broad range of diseases. The company develops medicines that can be delivered in lipid nanoparticles to durably and safely treat ...
Valuation
$0
Share Price
N/A
Total Raised
$82M
Last Round
N/A